Mark Lowenberg

MD PhD

Medical Specialist, Amsterdam Gastroenterology Endocrinology Metabolism Medical Specialist, Gastroenterology and Hepatology

Specialization

Gastroenterology and hepatology

Focus of research

Main research focus: optimizing treatment strategies with biologicals and immunomodulators in patients with inflammatory bowel diseases. Other research interests include: mucosal immunity, imaging (endoscopy, capsule endoscopy, cross-sectional imaging), intestinal fibrosis and pharmacokinetic studies.

Key publications
Latest publications

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity
on behalf of the T2B! immunity against SARS-CoV-2 study group, 1 Dec 2023, In: BMC Infectious Diseases. 23, 1, 332.
Research output: Contribution to journal › Article › Academic › peer-review
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial
Löwenberg, M., Volkers, A., van Gennep, S., Mookhoek, A., Montazeri, N., Clasquin, E., Duijvestein, M., van Bodegraven, A., Rietdijk, S., Jansen, J., van Asseldonk, D., van der Zanden, E., Dijkgraaf, M., West, R., de Boer, N. & D'Haens, G., 1 Jul 2023, In: Journal of Crohn's and Colitis. 17, 7, p. 1055-1065 11 p.
Research output: Contribution to journal › Article › Academic › peer-review
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases
Wieske, L., Stalman, E. W., van Dam, P. J. K., Kummer, L. Y., Steenhuis, M., van Kempen, Z. L. E., Killestein, J., Volkers, A. G., Tas, S. W., Boekel, L., Wolbink, G., van der Kooi, A., Raaphorst, J., Löwenberg, M., Takkenberg, B., D'Haens, G. R. A. M., Spuls, P. I., Bekkenk, M. W., Musters, A. H., Post, N. F., & 38 othersBosma, A. L., Hilhorst, M. L., Vegting, Y., Bemelman, F. J., Voskuyl, A., Broens, B., Parra Sanchez, A., van Els, C. C. A. C. M., Wit, J. D., Rutgers, A., de Leeuw, K., Horváth, B., Verschuuren, J. J. G. M., Ruiter, A. M., van Ouwerkerk, L., van der Woude, D., Allaart, C. F., Teng, Y. K. O., van Paassen, P., Busch, M. H., Jallah, P. B. P., Brusse, E., van Doorn, P. A., Baars, A. E., Hijnen, D., Schreurs, C. R. G., van der Pol, W. L., Goedee, H. S., Keijzer, S., Keijser, J., Cristianawati, O., ten Brinke, A., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., Kuijpers, T. W., Rispens, T. & Eftimov, F., 1 Jun 2023, In: Annals of the rheumatic diseases. 82, 6, p. 883-885 3 p., ard-2022-223464.
Research output: Contribution to journal › Review article › Academic › peer-review
All publications

Mark Lowenberg

Specialization

Focus of research

Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn's Disease

Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial

Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn’s disease; the Sensitivity to Change (STOC) study

Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity

Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial

Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases